Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 6.41
-0.06 (-0.93%)
Oct 10, 2025, 5:00 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 26.16 million as of October 10, 2025. Its market cap has decreased by -65.44% in one year.
Market Cap
26.16M
Enterprise Value
40.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.41
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has decreased from 26.85M to 26.16M, a decrease of -2.55%. That is a compound annual growth rate of -0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 26.16M | -59.42% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | 184.42M | 226.98% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.11B |
| NEUCA | 3.24B |
| Synektik Spólka Akcyjna | 2.27B |
| Voxel | 1.85B |
| Celon Pharma | 1.22B |
| Selvita | 675.48M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Ryvu Therapeutics | 506.61M |